Translation of "Arzneimittelgesetz" in English

What is covered by the pharmaceutical legislation or. the Medicines Act (AMG)

Does homeopathy need a unique position in the Medicines Act?

Previous PostPrevious Does homeopathy need a unique position in the Medicines Act?

Otherwise it may be concerned by the drug law.

The drug law explicitly provides the use of unauthorized drugs.

It and its coworkers are against the medicament law to have offended.

It and its coworkers are against the medicament law to have offended.

In Germany the authorized health insurance funds are not entitled to set up their own pharmacies.

The Institut Dr. Lörcher is permitted for testing according to § 14 AMG (Medicines Law).

The legal framework for the conduct of clinical trials in Germany is regulated by the German Drug Law.

In the drug sector aldehydes and ketones often have to be absent also due to directives of the Medicines Act.

As Popper fall under the Medicines Act, they may not be sold freely in Germany.

The German Drug Law and the implementing regulations enact the specifications of European law in Germany.

In my opinion, substances that are used to treat and alleviate the symptoms of serious illnesses, of illnesses that may not yet be curable at the present time, should be covered by legislation on medicinal products and have nothing to do with the consumption of foodstuffs.

A Clinical Research Associate (CRA), also called a clinical monitor or trial monitor, is a health-care professional who performs many activities related to medical research, particularly clinical trials.

Given the direct impact on the human body medicines have, the Law on Pharmaceuticals provided for this solution.

Although it is understandable that, confronted with a legal vacuum, Germany sought to apply legislation relating to medicinal products in order to be better able to control and prevent the marketing of those new substances, Advocate General Bot concludes that such an aim is not however capable of warranting a broad interpretation, indeed a distortion, of the concept of ‘medicinal product’.

It can therefore only be marketed in Germany after authorisation as a medicinal product under the medicinal products law.

According to those provisions, medicinal products, even if they are authorised in one Member State, must also, if they are to be placed on the market of another Member State, have been authorised either by the competent authority of that State or under the Community rules referred to in those provisions.

The opinion which received significant support was that, as a common minimum, ketamine should be subject to control under medicines legislation in the Member States due to the large legitimate use of ketamine for veterinary medicine.

However, another opinion firmly expressed was that, in addition to medicines legislation, stronger measures of control were necessary to deal with diversion, trafficking and inadvertent exposure (i.e. through fake 'ecstasy' tablets).

In Member States where regulation of medicinal products requires a notification or an application for approval before a trial is commenced the national rules must be consulted and complied with.

The gradient pressure of the softener from wall region to wall region may be built up in such a manner that, even theoretically, pressure equalization in such medical working means is impossible during the storage period permitted for such working means according to pharmaceutics legislation.

For simplicity, reference is made to the legal regulations of the Federal Republic of Germany (for example cosmetics legislation, Food and Drugs Act) for a clear distinction between cosmetic and medicinal use and corresponding products.

For the sake of simplicity, in order to distinguish clearly between cosmetic and medicinal use and corresponding products, reference is made to the legal provisions in the Federal Republic of Germany (for example Cosmetics Directive, Foods and Drugs Act).